B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes
This study expands the role of B lymphocytes in type 1 diabetes by demonstrating how B cells influence the development and function of regulatory T cells (Tregs) during islet transplant and autoimmune progression. This study was done to explain how B lymphocytes regulate the progression of anti-islet immunity, even when they appear dispensable for effector cell activation. B-cell deficiency (using NOD.μMT mice) enables durable islet transplant tolerance, enhances the expansion of Helios+ Tregs, increases the ratio of insulin-reactive Tregs to effector T cells, and enhances islet-protective Treg function. These findings indicate that B lymphocytes accelerate destructive immunity by negatively regulating Treg development and function. Targeting the harmful B-cell-Treg interactions, particularly in the thymic environment, may offer new, more selective therapeutic strategies to prevent anti-islet immunity.
Authors
- Alexander Falk (ORCID: https://orcid.org/0000-0003-2106-9413)
- Daniel J. Moore (ORCID: https://orcid.org/0000-0002-6889-9345)
- Blair T. Stocks
- Christopher Wilson (ORCID: https://orcid.org/0000-0002-7562-8420)
Institutions
- Baylor College of Medicine (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Diabetes
- Published
- 2025-11-25
- DOI
- https://doi.org/10.2337/db25-0241
- Citations
- 2
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.63